Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate
Abstract
Data di Pubblicazione:
2018
Tipologia CRIS:
1.5 Abstract in rivista
Elenco autori:
Santoro, A; Castagna, L; Magagnoli, M; Bramanti, S; Mariotti, J; Mazza, R; Morello, L; Ricci, F; Sarina, B; De Philippis, C; Sica, S; Rodari, M; Sollini, M; Kirienko, M; Giordano, L; Chiti, A; Corradini, P; Carlo-Stella, C
Link alla scheda completa:
Pubblicato in: